Social signalling and schizophrenia: the significance of neurochemical and morphological abnormalities of the basolateral circuit

J F Deakin; D. M. Simpson; P Slater; M.C. Royston

Social signalling and schizophrenia: the significance of neurochemical and morphological abnormalities of the basolateral circuit

J F Deakin, D. M. Simpson, P Slater, M.C. Royston

Division of Neuroscience

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	495A-497A
Journal	Clinical Neuropharmacology
Volume	15 Suppl 1 Pt A
Publication status	Published - 1992

Keywords

8-Hydroxy-2-(di-n-propylamino)tetralin
Brain Chemistry
Frontal Lobe
Humans
Schizophrenia
Schizophrenic Psychology
Social Behavior
Temporal Lobe
Tetrahydronaphthalenes
Journal Article

Cite this

@article{83fa440a2b6c4cc2bc94ea91c9c5b87a,

title = "Social signalling and schizophrenia: the significance of neurochemical and morphological abnormalities of the basolateral circuit",

keywords = "8-Hydroxy-2-(di-n-propylamino)tetralin, Brain Chemistry, Frontal Lobe, Humans, Schizophrenia, Schizophrenic Psychology, Social Behavior, Temporal Lobe, Tetrahydronaphthalenes, Journal Article",

author = "Deakin, {J F} and Simpson, {D. M.} and P Slater and M.C. Royston",

year = "1992",

language = "English",

volume = "15 Suppl 1 Pt A",

pages = "495A--497A",

journal = "Clinical Neuropharmacology",

issn = "0362-5664",

publisher = "Lippincott Williams & Wilkins",

}

TY - JOUR

T1 - Social signalling and schizophrenia

T2 - the significance of neurochemical and morphological abnormalities of the basolateral circuit

AU - Deakin, J F

AU - Simpson, D. M.

AU - Slater, P

AU - Royston, M.C.

PY - 1992

Y1 - 1992

KW - 8-Hydroxy-2-(di-n-propylamino)tetralin

KW - Brain Chemistry

KW - Frontal Lobe

KW - Humans

KW - Schizophrenia

KW - Schizophrenic Psychology

KW - Social Behavior

KW - Temporal Lobe

KW - Tetrahydronaphthalenes

KW - Journal Article

M3 - Article

C2 - 1386782

SN - 0362-5664

VL - 15 Suppl 1 Pt A

SP - 495A-497A

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

ER -